Canadian Cancer Trials Group Bulletins


ASCO 2013

A number of abstracts related to Canadian Cancer Trials Group trials or trials which included Canadian Cancer Trials Group participation are being presented at the American Society of Clinical Oncology Annual Meeting in Chicago, May 31 - June 4, 2013, including three that have been selected as oral presentations.

Canadian Cancer Trials Group OV.16
Session Title: Gynecologic Cancer
Session Type: Oral Abstract Session
Date: Sat, Jun 1
Location: E354b
Time: 3:00 PM - 6:00 PM
Chair and/or Co-Chairs: Paul Haluska, MD, PhD, and Gini F. Fleming, MD
3:30 PM - 3:45 PM Final results of OV16, a phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel (CP) versus CP in first-line chemotherapy for advanced epithelial ovarian cancer (EOC): A GCIG study of Canadian Cancer Trials Group, EORTC-GCG, and GEICO. (Abstract #5502) Andres Cervantes-Ruiperez, MD

Canadian Cancer Trials Group CE.5
Session Title: Central Nervous System Tumors
Session Type: Oral Abstract Session
Date: Sat, Jun 1
Location: E253
Time: 3:00 PM - 6:00 PM
Chair and/or Co-Chairs: Howard A. Fine, MD, and Mark R. Gilbert, MD
5:15 PM - 5:30 PM Temozolomide chemotherapy versus radiotherapy in molecularly characterized (1p loss) low-grade glioma: A randomized phase III intergroup study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033). (Abstract #2007) Brigitta G. Baumert, MD, PhD, MBA

Canadian Cancer Trials Group SC.20
Session Title: Patient and Survivor Care
Session Type: Oral Abstract Session
Date: Sun, Jun 2
Location: S100a
Time: 8:00 AM - 11:00 AM
Chair and/or Co-Chairs: Tara O. Henderson, MD, MPH
8:30 AM - 8:45 AM A randomized trial of single versus multiple fractions (Fx) for re-irradiation (RE-RT) of painful bone metastases (PBM): Canadian Cancer Trials Group SC.20. (Abstract #9502) Edward Chow, MBBS PhD

For a complete listing of abstracts being presented, please use this link ...